Yüklüyor......
Targeted alpha anticancer therapies: update and future prospects
Targeted alpha therapy (TAT) is an emerging option for local and systemic cancer treatment. Preclinical research and clinical trials show that alpha-emitting radionuclides can kill targeted cancer cells while sparing normal cells, thus reducing toxicity. (223)RaCl(2) (Xofigo(®)) is the first alpha e...
Kaydedildi:
| Yayımlandı: | Biologics |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232037/ https://ncbi.nlm.nih.gov/pubmed/25422581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S29947 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|